Clinical Trial Update: 3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol [Phase 3]

View source ↗

Summary

Phase 3 study protocol for a Systemic Lupus Erythematosus trial investigating taxonomy, treatment targets, and remission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: University Hospital, Brest | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 3 | Status: ACTIVE_NOT_RECRUITING